Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T12:50:25.459Z.
Calculation as of: 2026-10-06T12:50:25.459Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 026981202cadb8e73b6cbd63f18abfa8ffa74fea80ac6bbb32512047e0825b9f
EARNINGS YIELD
N/A
Market Cap
$2.69B
Earnings Yield
N/A
TTM Avg
8.33%
3Y Avg
6.72%
5Y Avg
5.70%
Market Cap
$2.69B
Earnings Yield
10.21%
TTM Avg
9.07%
3Y Avg
6.61%
5Y Avg
6.61%
Market Cap
$2.51B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.43B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.87B
Earnings Yield
4.65%
TTM Avg
3.82%
3Y Avg
2.33%
5Y Avg
2.33%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.64B | N/A | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | N/A | N/A | N/A | N/A |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | N/A | 8.33% | 6.72% | 5.70% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 10.21% | 9.07% | 6.61% | 6.61% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | N/A | N/A | N/A | N/A |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | N/A | N/A | N/A | N/A |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 0.38% | 0.43% | 0.43% | 1.84% |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 4.65% | 3.82% | 2.33% | 2.33% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | N/A | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 6.92% | 6.22% | 4.40% | 4.40% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
